The characteristics of mycobacterioses in patients with chronic lung diseases

A. Sargsyan (Moscow, Russian Federation), N. Makaryants (Moscow, Russian Federation), L. Lepekha (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation)

Source: International Congress 2019 – Airway infection in COPD
Session: Airway infection in COPD
Session type: Thematic Poster
Number: 2900
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sargsyan (Moscow, Russian Federation), N. Makaryants (Moscow, Russian Federation), L. Lepekha (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation). The characteristics of mycobacterioses in patients with chronic lung diseases. 2900

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tele-rehabilitation in chronic lung diseases
Source: ERS Course 2017
Year: 2017

Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Epidemiological profile of chronic interstitial lung diseases in Tunisian patients
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017


The impact of COVID-19 on children with chronic suppurative lung disease
Source: Virtual Congress 2021 – Respiratory function after COVID-19 and mechanical ventilation
Year: 2021



Post-viral effects on the susceptibility of developing chronic lung diseases
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021


Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020


A level of an alpha-1-proteinihibitor in patients with chronic bronchitis and lung tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 339s
Year: 2003

Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Impact of COVID-19 on patients with chronic lung disease
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021


Granulomatous lung diseases in operated patients
Source: Eur Respir J 2006; 28: Suppl. 50, 540s
Year: 2006

Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients
Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector
Year: 2007


Pulmonary manifestations in adult patients with chronic granulomatous disease
Source: Eur Respir J 2015; 45: 1613-1623
Year: 2015



Fungal VAP
Source: Eur Respir Mon 2011; 53: 122-137
Year: 2011


A study of hematologic disorders in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Subsequent COPD and lung cancer in patients with autoimmune disease
Source: Eur Respir J 2011; 37: 463
Year: 2011


The role of respiratory viruses in etiological structure of exacerbation of chronic and recurrent lung diseases in children
Source: Eur Respir J 2007; 30: Suppl. 51, 391s
Year: 2007

Prevalence and characteristics of cystic lung lesions in children with interstitial lung diseases – a register-based study
Source: Virtual Congress 2021 – Paediatric bronchology
Year: 2021



The threat in chronic lung diseases: acute exacerbations
Source: Eur Respir Rev, 26 (145) 170075; 10.1183/16000617.0075-2017
Year: 2017